PRECIGEN Investors


European Association for the Study of Diabetes (EASD) 57th Annual Meeting

Oct 01, 2021 at 12:00 PM CEST

The abstract entitled, "AG019 ActoBiotics as monotherapy or in association with teplizumab in recent-onset type 1 diabetes was safe and demonstrated encouraging metabolic and immunological effects" was presented by Chantal Mathieu, MD, PhD, Professor of Medicine at the Katholieke Universiteit Leuven, Belgium.

Supporting Materials